Key result
In conscious rabbits, candesartan reduced resting mean arterial pressure and enhanced the depressor response to hemorrhage, but did not significantly alter hemodynamic or renal responses to hypoxia or plasma volume expansion.
Why the study?
Does candesartan alter systemic and renal hemodynamic responses to stress and altered blood volume in conscious rabbits?
Does candesartan alter systemic and renal hemodynamic responses to stress and altered blood volume in conscious rabbits?
AT1-receptor activation supports mean arterial pressure and glomerular filtration rate during hypovolemia but plays little role in responses to hypoxia or plasma volume expansion.
Answers are grounded in this paper and cite their sources.
Candesartan effects in rabbits highlight hypovolemia-specific AT1 support; leaves open differential roles across stresses for further study.
We examined how systemic blockade of type 1 angiotensin (AT(1)-) receptors affects reflex control of the circulation and the kidney. In conscious rabbits, the effects of candesartan on responses of systemic and renal hemodynamics and renal excretory function to acute hypoxia, mild hemorrhage, and plasma volume expansion were tested. Candesartan reduced resting mean arterial pressure (MAP, -8 ± 2%) without significantly altering cardiac output (CO), increased renal blood flow (RBF, +38 ± 9%) and reduced renal vascular resistance (RVR, -32 ± 6%). Glomerular filtration rate (GFR) was not significantly altered but sodium excretion (U(Na+)V) increased fourfold. After vehicle treatment, hypoxia (10% inspired O(2) for 30 min) did not significantly alter MAP or CO, but reduced heart rate (HR, -17 ± 6%), increased RVR (+33 ± 16%) and reduced GFR (-46 ± 16%) and U(Na+)V (-41 ± 17%). Candesartan did not significantly alter these responses. After vehicle treatment, plasma volume expansion increased CO (+35 ± 7%), reduced total peripheral resistance (TPR, -26 ± 5%), increased RBF (+62 ± 23%) and reduced RVR (-32 ± 9%), but did not significantly alter MAP or HR. It also increased U(Na+)V (803 ± 184%) yet reduced GFR (-47 ± 9%). Candesartan did not significantly alter these responses. After vehicle treatment, mild hemorrhage did not significantly alter MAP but increased HR (+16 ± 3%), reduced CO (-16 ± 4%) and RBF (-18 ± 6%), increased TPR (+18 ± 4%) and tended to increase RVR (+18 ± 9%, P = 0.1), but had little effect on GFR or U(Na+)V. But after candesartan treatment MAP fell during hemorrhage (-19 ± 1%), while neither TPR nor RVR increased, and GFR (-64 ± 18%) and U(Na+)V (-83 ± 10%) fell. AT(1)-receptor activation supports MAP and GFR during hypovolemia. But AT(1)-receptors appear to play little role in the renal vasoconstriction, hypofiltration, and antinatriuresis accompanying hypoxia, or the systemic and renal vasodilatation and natriuresis accompanying plasma volume expansion.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2011) studied Healthy (normotensive) (n=7). Candesartan vs. Vehicle (0.9% NaCl) was evaluated on Resting mean arterial pressure (MAP) (p=0.01). In conscious rabbits, candesartan reduced resting mean arterial pressure and enhanced the depressor response to hemorrhage, but did not significantly alter hemodynamic or renal responses to hypoxia or plasma volume expansion.
Synapse has enriched 10 related papers. Consider them for comparative context: